What does peptide care cost?

In September 2026, most of the national online services checked for help with weight loss charged a monthly membership; medicine cost extra.

Ask an Austin practice how it charges for care. Do not assume its bill follows this pattern.

• CareVisit or membership fee
• MedicineThe prescription’s price
• TestsAny separate bill for tests

Ask what a normal month costs, what must be paid up front, and what happens if you stop. Get the answer in writing.

As of September 2026, medicine makers advertised cash offers of about $149 to $499 a month for several brand-name weight and diabetes medicines.

Self-pay means paying outside insurance; some offers charge more when a refill is late.

Semaglutide, sold as Ozempic, is a medicine for type 2 diabetes; the example below is for its injection pen, a device that gives a shot.

Strength means the amount of medicine listed on the prescription. Match your prescription to the offer terms.

The Ozempic pen offer in September 2026 charged $199 for each of the first two monthly fills, at either 0.25 mg or 0.5 mg.

After those two fills, monthly prices were $349 for a 1 mg, 0.5 mg, or 0.25 mg prescription and $499 for 2 mg.

Through December 31, 2026, the opening offer applies to US patients who are new, at least 18 years old, and paying outside insurance.

The offer does not allow an insurance refund or counting the payment toward your insurance deductible, the amount paid before insurance starts paying.

Ask which price applies to your written prescription. The medicine price still leaves the cost of care to ask about.

At the September 2026 check, many cash offers and savings cards listed December 31, 2026 as their term end.

Confirm the terms again before a later refill. Other peptide care needs its own written quote.

As of September 2026, Medicare’s regular prescription-drug coverage, called Part D, excludes medicines prescribed for weight loss.

Your plan may pay for a medicine prescribed for an approved diabetes use; ask it to check your prescription.

Give your plan the medicine’s exact name and explain why it is being prescribed when you ask about coverage. “Prior authorization” means the insurer’s advance decision about paying.

GLP-1 medicines help with blood sugar or weight, depending on the product.

A copay is the part of the bill you pay.

As of September 2026, patients who qualify pay a $50 copay each month through Medicare’s temporary GLP-1 Bridge program.

The Bridge covers semaglutide (Wegovy), a weight-loss medicine, as shots or tablets.

It also covers tirzepatide (Zepbound), another weight-loss medicine, only in the KwikPen device that gives a shot.

Zepbound single-dose pens and vials, small medicine bottles, are excluded.

Orforglipron (Foundayo), a weight-loss tablet, is also on the list.

Ask which medicine is covered for your reason for treatment.

The Bridge runs outside Medicare’s usual drug benefit, beginning on July 1, 2026 and ending on December 31, 2027.

Eligibility requires an age of at least 18, plus drug coverage from Medicare through a Part D plan or an eligible Medicare Advantage plan.

The weight test relies on body mass index (BMI), a value calculated from height and weight. Ask your doctor for your BMI when this treatment began.

You must meet one of these conditions when treatment began:

• BMI of at least 35.
• BMI of at least 30, together with a specified heart failure type, high blood pressure that remains uncontrolled, or kidney disease at stage 3a or beyond.
• BMI of at least 27, plus prediabetes, a past stroke or heart attack, or disease of arteries outside the heart that causes symptoms.

Ask your doctor to confirm that your diagnosis is the required type: “heart failure with preserved ejection fraction”.

The blood pressure rule requires a top reading above 140 or a bottom reading above 90, despite treatment with two blood pressure medicines.

Ask your doctor to confirm your kidney disease stage, which describes how far it has progressed. With prediabetes, blood sugar is above normal but still below the range for diabetes.

A prescription and the program’s advance approval are required, along with an ongoing plan for food choices and physical activity.

Type 2 diabetes makes you ineligible for the $50 Bridge offer; ask your regular Medicare drug plan about coverage instead.

The Bridge also excludes moderate or severe obstructive sleep apnea, a condition in which breathing is repeatedly blocked during sleep.

The liver disease MASH is also excluded when there is moderate or advanced scarring but no cirrhosis, the name for severe scarring.

A prescription to help prevent heart attacks, strokes or death from heart or blood-vessel disease also goes to the regular Medicare drug plan.

For 2026, you cannot use the Bridge if a GLP-1 medicine was paid for by your regular Medicare drug plan at any point during 2026.

Ask your doctor and Medicare plan to check your diagnoses, plan type, and past coverage before relying on the offer.

The $50 Bridge payment does not count toward the yearly cap on what you pay for medicines covered by your regular Medicare drug plan.

Low-income help does not lower this payment.